Abel BioSolutions

Abel Biosolutions, formed in August 2010, is a vaccine and bioprocess industry solution provider, and is currently focused on development of preventive & therapeutic health care vaccines and biologics. The major research focus areas are latest generation vaccines and designer biologics for various human and animal infectious diseases caused by bacterial and viral pathogens. ABEL BioSolutions is also targeting a vast market that is emerging as a result of the withdrawal of harmful chemicals and antibiotics in animal agriculture by developing antibiotic replacement therapies.